Tool predicts response to combo therapy in metastatic renal carcinomaAim is to avoid cost and side-effects of dual treatment if chances of benefiting are low Pregnancy may be compatible with breast cancer Colorectal cancer survival data raise questions Administrative health database cohort trial finds IIB patients exhibit worse overall survival than stage III patients Colon screening regimen confirmed Oncology | Breast screening controversy hits Denmark Tool helps predict survival in metastatic renal carcinoma Aim is to avoid cost and side-effects of combo therapy if chances of benefiting are low Oncology | Targeted radiation improves lung cancer survival Take a walk on the bile side Score predicts liver cancer in chronic hep B carriers System allows physicians to prioritize patients for screening and antiviral therapy Jurnista: new once-daily hydromorphone First Previous 69 70 71 72 73 Next Last
